QRS micro-fragmentation as a mortality predictor
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
MR/M006638/1
Medical Research Council - United Kingdom
MR/R024227/1
Medical Research Council - United Kingdom
MR/S011676/1
Medical Research Council - United Kingdom
NH/16/2/32499
British Heart Foundation - United Kingdom
PubMed
35187560
PubMed Central
PMC9584751
DOI
10.1093/eurheartj/ehac085
PII: 6533247
Knihovny.cz E-resources
- Keywords
- Electrocardiogram, Fragmentation, Mortality prediction, QRS complex,
- MeSH
- Electrocardiography * methods MeSH
- Humans MeSH
- Predictive Value of Tests MeSH
- Prognosis MeSH
- Risk Factors MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
AIMS: Fragmented QRS complex with visible notching on standard 12-lead electrocardiogram (ECG) is understood to represent depolarization abnormalities and to signify risk of cardiac events. Depolarization abnormalities with similar prognostic implications likely exist beyond visual recognition but no technology is presently suitable for quantification of such invisible ECG abnormalities. We present such a technology. METHODS AND RESULTS: A signal processing method projects all ECG leads of the QRS complex into optimized three perpendicular dimensions, reconstructs the ECG back from this three-dimensional projection, and quantifies the difference (QRS 'micro'-fragmentation, QRS-μf) between the original and reconstructed signals. QRS 'micro'-fragmentation was assessed in three different populations: cardiac patients with automatic implantable cardioverter-defibrillators, cardiac patients with severe abnormalities, and general public. The predictive value of QRS-μf for mortality was investigated both univariably and in multivariable comparisons with other risk factors including visible QRS 'macro'-fragmentation, QRS-Mf. The analysis was made in a total of 7779 subjects of whom 504 have not survived the first 5 years of follow-up. In all three populations, QRS-μf was strongly predictive of survival (P < 0.001 univariably, and P < 0.001 to P = 0.024 in multivariable regression analyses). A similar strong association with outcome was found when dichotomizing QRS-μf prospectively at 3.5%. When QRS-μf was used in multivariable analyses, QRS-Mf and QRS duration lost their predictive value. CONCLUSION: In three populations with different clinical characteristics, QRS-μf was a powerful mortality risk factor independent of several previously established risk indices. Electrophysiologic abnormalities that contribute to increased QRS-μf values are likely responsible for the predictive power of visible QRS-Mf.
Department of Cardiology and Pneumology University Medical Center Göttingen Germany
Department of Cardiology Inselspital Bern University Hospital Bern Switzerland
Department of Cardiology University Hospital of Basel Basel Switzerland
Department of Cardiovascular Sciences University of Leuven Leuven Belgium
Department of Internal Medicine and Cardiology Masaryk University Brno Czech Republic
Department of Internal Medicine and Cardiology University Hospital Brno Brno Czech Republic
Department of Medical Physiology University Medical Center Utrecht Utrecht The Netherlands
Department of Medical Statistics University Medical Center Göttingen Göttingen Germany
German Center for Cardiovascular Research Partner Site Munich Heart Alliance Munich Germany
German Center of Cardiovascular Research Partner Site Göttingen Göttingen Germany
Klinikum rechts der Isar Technical University of Munich Munich Germany
Medical Research Center Oulu University Central Hospital of Oulu and University of Oulu Oulu Finland
Research Department of Epidemiology and Public Health University College London UK
University Hospital for Internal Medicine 3 Medical University Innsbruck Innsbruck Austria
Veteran Affairs and Georgetown University Medical Centers Washington DC USA
See more in PubMed
Peterson PN, Greiner MA, Qualls LG, Al-Khatib SM, Curtis JP, Fonarow GC, et al. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. JAMA 2013;310:617–626. PubMed
Bauer A, Watanabe MA, Barthel P, Schneider R, Ulm K, Schmidt G. QRS duration and late mortality in unselected post-infarction patients of the revascularization era. Eur Heart J 2006;27:427–433. PubMed
Das MK, Zipes DP. Fragmented QRS: a predictor of mortality and sudden cardiac death. Heart Rhythm 2009;6:S8–S14. PubMed
Terho HK, Tikkanen JT, Junttila JM, Anttonen O, Kenttä TV, Aro AL, et al. Prevalence and prognostic significance of fragmented QRS complex in middle-aged subjects with and without clinical or electrocardiographic evidence of cardiac disease. Am J Cardiol 2014;114:141–147. PubMed
Rosengarten JA, Scott PA, Morgan JM. Fragmented QRS for the prediction of sudden cardiac death: a meta-analysis. Europace 2015;17:969–977. PubMed
Cetin MS, Ozcan Cetin EH, Canpolat U, Cay S, Topaloglu S, Temizhan A, et al. Usefulness of fragmented QRS complex to predict arrhythmic events and cardiovascular mortality in patients with noncompaction cardiomyopathy. Am J Cardiol 2016;117:1516–1523. PubMed
Marume K, Noguchi T, Kamakura T, Tateishi E, Morita Y, Miura H, et al. Prognostic impact of multiple fragmented QRS on cardiac events in idiopathic dilated cardiomyopathy. Europace 2021;23:287–297. PubMed
Bokma JP, Winter MM, Vehmeijer JT, Vliegen HW, van Dijk AP, van Melle JP, et al. QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot. Heart 2017;103:666–671. PubMed
Roudijk RW, Bosman LP, van der Heijden JF, de Bakker JMT, Hauer RNW, van Tintelen JP, et al. Quantitative approach to fragmented QRS in arrhythmogenic cardiomyopathy: from disease towards asymptomatic carriers of pathogenic variants. J Clin Med 2020;9:545. PubMed PMC
Kelen GJ, Henkin R, Starr AM, Caref EB, Bloomfield D, el-Sherif N. Spectral turbulence analysis of the signal-averaged electrocardiogram and its predictive accuracy for inducible sustained monomorphic ventricular tachycardia. Am J Cardiol 1991;67:965–975. PubMed
Kulakowski P, Hnatkova K, Bashir Y, Heald SC, Staunton A, Malik M, et al. Influence of the infarct site on the identification of patients with ventricular tachycardia after myocardial infarction based on the time-domain and spectral turbulence analysis of the signal-averaged electrocardiogram. Clin Cardiol 1995;18:39–44. PubMed
Hnatkova K, Andršová I, Toman O, Smetana P, Huster KM, Šišáková M, et al. Spatial distribution of physiologic 12-lead QRS complex. Sci Rep 2021;11:4289. PubMed PMC
Sticherling C, Arendacka B, Svendsen JH, Wijers S, Friede T, Stockinger J, et al. Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries. Europace 2018;20:963–970. PubMed PMC
Zabel M, Malik M, Hnatkova K, Papademetriou V, Pittaras A, Fletcher RD, et al. Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in male US veterans. Circulation 2002;105:1066–1070. PubMed
Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991;337:1387–1393. PubMed
Jandackova VK, Britton A, Malik M, Steptoe A. Heart rate variability and depressive symptoms: a cross-lagged analysis over a 10-year period in the Whitehall II study. Psychol Med 2016;46:2121–2131. PubMed
Malik M, Andreas JO, Hnatkova K, Hoeckendorff J, Cawello W, Middle M, et al. Thorough QT/QTc study in patients with advanced Parkinson’s disease: cardiac safety of rotigotine. Clin Pharmacol Therap 2008;84:595–603. PubMed
Zabel M, Acar B, Klingenheben T, Franz MR, Hohnloser SH, Malik M. Analysis of 12-lead T-wave morphology for risk stratification after myocardial infarction. Circulation 2000;102:1252–1257. PubMed
Hnatkova K, Seegers J, Barthel P, Novotny T, Smetana P, Zabel M, et al. Clinical value of different QRS-T angle expressions. Europace 2018;20:1352–1361. PubMed PMC
Jr H F, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982;247:2543–2546. PubMed
Bauer A, Klemm M, Rizas KD, Hamm W, von Stülpnagel L, Dommasch M, et al. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study. Lancet 2019;394:1344–1351. PubMed
Dommasch M, Steger A, Barthel P, Huster KM, Müller A, Sinnecker D, et al. Nocturnal respiratory rate predicts ICD benefit: a prospective, controlled, multicentre cohort study. EClinicalMedicine 2021;31:100695. PubMed PMC
Ferrero P, Piazza I, Grosu A, Brambilla P, Sironi S, Senni M. QRS fragmentation as possible new marker of fibrosis in patients with myocarditis. Preliminary validation with cardiac magnetic resonance. Eur J Heart Fail 2019;21:1160–1161. PubMed
Bi X, Yang C, Song Y, Yuan J, Cui J, Hu F, et al. Quantitative fragmented QRS has a good diagnostic value on myocardial fibrosis in hypertrophic obstructive cardiomyopathy based on clinical-pathological study. BMC Cardiovasc Disord 2020;20:298. PubMed PMC
Englund A, Hnatkova K, Kulakowski P, Elliot PM, McKenna WJ, Malik M. Wavelet decomposition analysis of the signal averaged electrocardiogram used for risk stratification of patients with hypertrophic cardiomyopathy. Eur Heart J 1998;19:1383–1390. PubMed
Odemuyiwa O, Malik M, Poloniecki J, Farrell T, Kulakowski P, Millane T, et al. Frequency versus time domain analysis of signal-averaged electrocardiograms. III. Stratification of postinfarction patients for arrhythmic events. J Am Coll Cardiol 1992;20:144–150. PubMed
Arthur RM, Geselowitz DB, Briller SA, Trost RF. Quadrupole components of the human surface electrocardiogram. Am Heart J 1972;83:663–677. PubMed
Malik M. Electrocardiographic smoke signals of fragmented QRS complex. J Cardiovasc Electrophysiol 2013;24:1267–1270. PubMed
Zabel M, Willems R, Lubinski A, Bauer A, Brugada J, Conen D, et al. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study. Eur Heart J 2020;41:3437–3447. PubMed PMC
Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016;375:1221–1230. PubMed
Prognostic Significance and Associations of Neural Network-Derived Electrocardiographic Features
Development of autonomic heart rate modulations during childhood and adolescence
Speed of heart rate changes during postural provocations in children and adolescents
QRS complex and T wave planarity for the efficacy prediction of automatic implantable defibrillators